{"filing":{"accession_number":"0001477932-26-004421","cik":"0000093314","ticker":"VNRX","company_name":"VOLITIONRX LTD","form":"8-K","filing_date":"2026-07-21","report_date":null,"primary_document":"vnrx_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226004421/vnrx_8k.htm"},"events":[{"id":19138,"run_id":17222,"accession_number":"0001477932-26-004421","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"VolitionRx held its annual meeting of stockholders on July 17, 2026, with voting results on five proposals: election of seven directors, ratification of auditor (Sadler, Gibb \u0026 Associates, LLC), advisory vote on named executive officer compensation, amendment to reduce authorized shares from 325 million to 150 million, and approval of the 2026 Stock Incentive Plan.","company_name":"VOLITIONRX LTD","ticker":"VNRX","filing_date":"2026-07-21","form":"8-K","submitted_at":null,"items":[{"id":18145,"accession_number":"0001477932-26-004421","item_number":"5.03","item_title":"Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year.","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.85,"reasoning":"This disclosure describes a routine amendment to the Certificate of Incorporation reducing authorized common shares from 325 million to 150 million, approved by both the board (May 11, 2026) and stockholders at the Annual Meeting. While technically a governance matter, the reduction of authorized shares is an administrative capital structure adjustment that does not materially affect the registrant's financial condition, operations, or investor risk profile — it is a housekeeping measure rather than a material event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T20:17:26.072780+00:00","company_name":"","ticker":null,"filing_date":""},{"id":18146,"accession_number":"0001477932-26-004421","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the final voting results from VolitionRx's July 17, 2026 annual meeting of stockholders on five proposals: election of seven directors, ratification of auditor (Sadler, Gibb \u0026 Associates, LLC), advisory vote on named executive officer compensation, amendment to reduce authorized shares, and approval of the 2026 Stock Incentive Plan. The detailed tabulation of votes for, against, abstained, and broker non-votes for each proposal is the core content of a shareholder vote results disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T20:17:26.072780+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":18145,"accession_number":"0001477932-26-004421","item_number":"5.03","item_title":"Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year.","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.85,"reasoning":"This disclosure describes a routine amendment to the Certificate of Incorporation reducing authorized common shares from 325 million to 150 million, approved by both the board (May 11, 2026) and stockholders at the Annual Meeting. While technically a governance matter, the reduction of authorized shares is an administrative capital structure adjustment that does not materially affect the registrant's financial condition, operations, or investor risk profile — it is a housekeeping measure rather than a material event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T20:17:26.072780+00:00","company_name":"VOLITIONRX LTD","ticker":"VNRX","filing_date":"2026-07-21"},{"id":18146,"accession_number":"0001477932-26-004421","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the final voting results from VolitionRx's July 17, 2026 annual meeting of stockholders on five proposals: election of seven directors, ratification of auditor (Sadler, Gibb \u0026 Associates, LLC), advisory vote on named executive officer compensation, amendment to reduce authorized shares, and approval of the 2026 Stock Incentive Plan. The detailed tabulation of votes for, against, abstained, and broker non-votes for each proposal is the core content of a shareholder vote results disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T20:17:26.072780+00:00","company_name":"VOLITIONRX LTD","ticker":"VNRX","filing_date":"2026-07-21"}]}